These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17692907)

  • 1. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment.
    Zhou XC; Dowdy SC; Podratz KC; Jiang SW
    Gynecol Oncol; 2007 Oct; 107(1):143-53. PubMed ID: 17692907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epigenetics of ovarian cancer drug resistance and resensitization.
    Balch C; Huang TH; Brown R; Nephew KP
    Am J Obstet Gynecol; 2004 Nov; 191(5):1552-72. PubMed ID: 15547525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of the progesterone receptor by the methylation of progesterone receptor gene in endometrial cancer cells.
    Ren Y; Liu X; Ma D; Feng Y; Zhong N
    Cancer Genet Cytogenet; 2007 Jun; 175(2):107-16. PubMed ID: 17556066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of epigenetic therapy in multiple myeloma.
    Smith EM; Boyd K; Davies FE
    Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of epigenetics in urological cancers.
    Ramachandran K; Soloway MS; Singal R; Manoharan M
    Can J Urol; 2007 Jun; 14(3):3535-41. PubMed ID: 17594743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics, disease, and therapeutic interventions.
    Lu Q; Qiu X; Hu N; Wen H; Su Y; Richardson BC
    Ageing Res Rev; 2006 Nov; 5(4):449-67. PubMed ID: 16965942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of epigenetic alterations in pancreatic cancer.
    Sato N; Goggins M
    J Hepatobiliary Pancreat Surg; 2006; 13(4):286-95. PubMed ID: 16858539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
    Lyko F; Brown R
    J Natl Cancer Inst; 2005 Oct; 97(20):1498-506. PubMed ID: 16234563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation: a new research area for melatonin?
    Korkmaz A; Reiter RJ
    J Pineal Res; 2008 Jan; 44(1):41-4. PubMed ID: 18078446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA hypermethylation as a chemotherapy target.
    Ren J; Singh BN; Huang Q; Li Z; Gao Y; Mishra P; Hwa YL; Li J; Dowdy SC; Jiang SW
    Cell Signal; 2011 Jul; 23(7):1082-93. PubMed ID: 21345368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics in human disease and prospects for epigenetic therapy.
    Egger G; Liang G; Aparicio A; Jones PA
    Nature; 2004 May; 429(6990):457-63. PubMed ID: 15164071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
    Fleury L; Gerus M; Lavigne AC; Richard-Foy H; Bystricky K
    Oncogene; 2008 Jul; 27(29):4075-85. PubMed ID: 18317449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
    Watanabe Y; Toyota M; Kondo Y; Suzuki H; Imai T; Ohe-Toyota M; Maruyama R; Nojima M; Sasaki Y; Sekido Y; Hiratsuka H; Shinomura Y; Imai K; Itoh F; Tokino T
    Clin Cancer Res; 2007 Aug; 13(16):4786-94. PubMed ID: 17699856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
    Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
    Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenome: a new target in cancer therapy.
    Giacinti L; Vici P; Lopez M
    Clin Ter; 2008; 159(5):347-60. PubMed ID: 18998037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.